1. Evaluation of response to chemotherapy in retinoblastoma heterotransplanted to the eyes of nude mice

   • Les White
   • Bernard C. Szirth
   • William F. Benedict

   Original Articles Pages: 63 - 67

2. Tumor and serum tamoxifen concentrations in the athymic nude mouse

   • Michael W. DeGregorio
   • Ester Coronado
   • C. Kent Osborne

   Original Articles Pages: 68 - 70

3. Neurotoxicity and dermatotoxicity of cyanomorpholinyl adriamycin

   • Steven C. Cramer
   • Roy H. Rhodes
   • Zoltán A. Tökés

   Original Articles Pages: 71 - 75

4. Relevance of the hydrolysis and protein binding of melphalan to the treatment of multiple myeloma

   • S. Gera
   • E. Musch
   • U. Loos

   Original Articles Pages: 76 - 80

5. Analysis of the effect of liposome encapsulation on the vesicant properties, acute and cardiac toxicities, and antitumor efficacy of doxorubicin

   • J. A. E. Balazsovits
   • L. D. Mayer
   • R. E. Falk

   Original Articles Pages: 81 - 86

6. In vitro evidence for dose-dependent cytotoxicity as the predominant effect of low dose Ara-C on human leukemic and normal marrow cells

   • Clara S. P. Chan
   • Geraldine P. Schechter

   Original Articles Pages: 87 - 94

7. High-dose melphalan dosage adjustment: possibility of using a test-dose

   • Brigitte Tranchand
   • Yves-Dominique Ploin
   • Claude Ardiet

   Original Articles Pages: 95 - 100

8. Prospective evaluation of chronic cardiotoxicity due to high-dose epirubicin or combination chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil

   • H. Havsteen
   • I. Brynjolf
   • O. Munck

   Original Articles Pages: 101 - 104

9. Randomised trial comparing prednimustine with combination chemotherapy in advanced ovarian carcinoma

   • Robert C. F. Leonard
   • George E. Smart
   • John F. Smyth

   Original Articles Pages: 105 - 110

10. The relative effectiveness of analogues of cisplatin in the experimental chemotherapy of human non-small-cell lung cancer and neuroblastoma grown as multicellular spheroids

    • J. Russell
    • J. Adam
    • S. B. Kaye

    Original Articles Pages: 111 - 114

11. Mitomycin C treatment of advanced, hormone-resistant prostatic carcinoma: a phase II study

    • A. Veronesi
    • V. Dal Bo
    • S. Monfardini

    Original Articles Pages: 115 - 116

12. Enhanced cutaneous radiation effects following high-dose busulfan therapy

    • G. Vassal
    • O. Hartmann
    • J. Lemerle

    Original Articles Pages: 117 - 118

13. A new anticancer agent (LY186641) interferes with creatinine assay

    • Marc M. Bonnay
    • Gonzalo Recondo
    • Jean-Pierre Armand

    Short Communication Pages: 119 - 120

14. Fanconi syndrome after ifosfamide

    • Martin Moncrieff
    • Anabell Foot

    Short Communication Pages: 121 - 122

15. Phase II study of a new alkylating agent (PTT-119) in resistant-relapsed non-Hodgkin's lymphomas

    • S. Tura
    • P. Mazza
    • R. Zanchini

    Short Communication Pages: 123 - 125

16. Human pharmacokinetics of carboplatin after oral administration

    • Maaike B. van Hennik
    • Wim J. F. van der Vijgh
    • Herbert M. Pinedo

    Letter to the Editors Pages: 126 - 127

17. Failure of response to ifosfamide in squamous cell bronchogenic carcinoma

    • J. Banks
    • E. G. Anderson
    • A. P. Smith

    Letter to the Editors Pages: 128 - 128